Wednesday, July 8, 2026

Drug profile · INN

technetium tc-99m albumin aggregated kit

technetium tc-99m albumin aggregated kit (MACROTEC) is a diagnostic. Associated with AXIM BIOTECHNOLOGIES, INC.. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 20
Pipeline programs 0
News articles 0
Drug details — technetium tc-99m albumin aggregated kit
US status
approved
Class
Route
INJECTION
Patents
20
Programs
0
Data quality
0.89

Quick answer

technetium tc-99m albumin aggregated kit (MACROTEC) is a diagnostic. Associated with AXIM BIOTECHNOLOGIES, INC.. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN technetium tc-99m albumin aggregated kit
Brand MACROTEC
Mechanism Diagnostic
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Diagnostic

Approval history

Authority Status Date
FDA approved
  1. US 12144876

    Security mechanisms for radiopharmaceutical elution system and elution process

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12018125

    Block-copolymers for the delivery of active agents

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11904028

    Security mechanisms for radiopharmaceutical elution system and elution process

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11857647

    Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 11672771

    Beta-alethine, immune modulators, and uses thereof

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 11542226

    Polyfunctional cannabinoids

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 11229700

    Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 11206824

    Gas delivery device comprising a gas releasing molecule and a gas permeable membrane

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 11028144

    Soluble glycoprotein V for treating thrombotic diseases

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 10822378

    Mutated structural protein of a parvovirus

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 10543190

    Suppositories comprising cannabinoids

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 10435373

    Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 10434117

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 10272051

    Method to treat atopic dermatitis

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 10172786

    Oral care composition comprising cannabinoids

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 10092538

    Suppositories comprising cannabinoids

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 10071966

    Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 10028974

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 10010571

    Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of use thereof

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 9663788

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is technetium tc-99m albumin aggregated kit?

technetium tc-99m albumin aggregated kit (MACROTEC) is a diagnostic. Associated with AXIM BIOTECHNOLOGIES, INC.. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for technetium tc-99m albumin aggregated kit?

MACROTEC is a marketed brand name for technetium tc-99m albumin aggregated kit. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of technetium tc-99m albumin aggregated kit?

technetium tc-99m albumin aggregated kit has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.